Skip to main content
. 2016 Mar 21;23(6):348–351. doi: 10.1136/ejhpharm-2015-000848

Table 1.

Overview for assessing clinical impact

Level Descriptor Examples
1 None/insignificant—no harm would have occurred to the patient.
  • Wrong timing when optimal timing desirable but not critical

  • ‘As required’ medicines that have only been required minimally during the admission not prescribed on discharge

2 Low/minor—would have caused minimal harm. May have required extra observation or minor treatment.
  • Regular or ‘as required’ medications taken prior to the admission and not prescribed, eg, topical preparations, laxatives, etc.

  • Inappropriate continuation of a medicine with a good safety profile

  • Brand not stated when this might impact on clinical outcome according to British National Formulary guidance

3 Moderate—could have resulted in a moderate increase in treatment with significant but not permanent harm to the patient.
  • Omitted or inappropriately prescribed long-term medicine (stopped drug restarted, therapeutic duplicate)

  • Wrong drug or wrong dose; wrong route, wrong dose frequency

  • Wrong brand when this is important according to British National Formulary guidance

  • No instructions to step up or step down medications

  • No stop date for short course of medicines

4 Severe/major—could have resulted in permanent harm
  • Errors involving the prescribing of high-risk drugs or failure to arrange monitoring in early stages of dose stabilisation

  • New allergy or serious adverse drug event not documented